We have observed
15 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 23, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
MEANS FOR THE TRANSIENT PRODUCTION IN PLANTS OF RECOMBINANT PROTEINS THAT CAN BE USED IN PARTICULAR IN PROPHYLAXIS AND IN THERAPEUTICS
METHOD FOR CHARACTERISING THE ORIGIN AND/OR CONDITION OF DISEASED OR HEALTHY CELLS, AND USES THEREOF IN BIOLOGY
METHOD FOR MANUFACTURING EDIBLE TRANSPARENT MATERIALS THAT CAN BE USED AS CONTAINERS FOR FOOD PRODUCTS, AND USES THEREOF
PROPOFOL FOR USE AS AN ANTIVIRAL MEDICAMENT
NON COVALENT MOLECULAR STRUCTURE, COMPRISING A PYRENE BASED GLYCOCONJUGATE, DEVICE COMPRISING THE SAME AND ITS USE FOR DETECTION OF LECTIN
CLICKED SOMATOSTATIN CONJUGATED ANALOGS FOR BIOLOGICAL APPLICATIONS
METHOD FOR EVALUATING FLAVOR IMPROVING AGENT
Tools and method for the detection and quantification of genetically diverse HIV-1, SIVcpz and SIVgor viruses
Stability of silage inoculants and methods for improving aerobic stability of silage
Support for the culture of adherent cells and method for their detachment
GALVINOXYL DERIVATIVE FOR USE THEREOF AGAINST LIPOPROTEIN-ENVELOPED VIRUSES, IN PARTICULAR HERPESVIRUSES
NON COVALENT MOLECULAR STRUCTURE, DEVICE COMPRISING THE SAME AND ITS USE FOR THE DETECTION OF A LECTIN
Clicked somatostatin conjugated analogs for biological applications
GLYCOMIMETIC COMPOUNDS AS ANTI-INFECTIOUS AGAINST PATHOGENS LECTINS